[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615682":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":42,"collaborators":10,"id":46,"slug":10,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":10,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Jagiellonian University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Women with urine incontinence\u002F uterine prolapse",null,"Healthy women with urine incontinence\u002F uterine prolapse qualified for urogynecological surgery",[13],"Diagnostic Test: determination of fibrin clot properties",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","determination of fibrin clot properties","Determination of fibre clot properties and thrombin generation in women with uterine prolapse\u002F urine incontinence before and after urogynecological surgery.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Magdalena MP Piróg, MD, PhD","CONTACT","+48 604514915","magda.m.pulka@gmail.com",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Gynecological Endocrinology Department","RECRUITING","Krakow","Małopolska","31-501","Poland",{"type":35,"coordinates":36},"Point",[37,38],19.93658,50.06143,{"lat":38,"lon":37},[41],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Magdalena Piróg, MD","MD, PhD","100615682",false,"NCT07295782","The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.","Fibrin Clot Properties and Thrombin Generation in Women After Urogynecological Surgery.","Inclusion Criteria:\n\n* Age 18-70\n* treatment failure (pharmacotherapy) due to uterine prolapse or urine incontinence\n\nExclusion Criteria:\n\n* prolonged thromboprophylaxis\n* planned surgery other than due to urine incontinence\u002Futerine prolapse\n* acquired or congenital thrombophilia",true,"FEMALE","18 Years","70 Years",{"count":57,"type":58},60,"ESTIMATED","OBSERVATIONAL","Determination of fibrin clot properties along with thrombin generation in women after urigynecological surgery.",[62,63],"Uterine Prolapse","Urine Incontinence",[65,66,67,68,69],"uterine prolapse","urine incontinence","fibrin clot","fibrinolysis","thrombin","2025-12-08",{"date":72,"type":73},"2025-12-22","ACTUAL",{"date":75,"type":58},"2025-12-10",{"date":77,"type":58},"2026-05-30",{"name":5,"class":6},1]